Enrique A. Conterno
2016
In 2016, Enrique A. Conterno earned a total compensation of $4.6M as Senior Vice President and President, Lilly Diabetes at Lilly Eli & Co, a 19% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $935,408 |
|---|---|
| Non-Equity Incentive Plan | $681,371 |
| Salary | $727,960 |
| Stock Awards | $2,200,000 |
| Other | $43,678 |
| Total | $4,588,417 |
Conterno received $2.2M in stock awards, accounting for 48% of the total pay in 2016.
Conterno also received $935.4K of change in pension value and nonqualified deferred compensation earnings, $681.4K in non-equity incentive plan, $728K in salary and $43.7K in other compensation.
Rankings
In 2016, Enrique A. Conterno's compensation ranked 1,836th out of 14,075 executives tracked by ExecPay. In other words, Conterno earned more than 87.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,836 out of 14,075 | 87th |
Division Manufacturing | 623 out of 5,489 | 89th |
Major group Chemicals And Allied Products | 176 out of 1,895 | 91st |
Industry group Drugs | 123 out of 1,538 | 92nd |
Industry Pharmaceutical Preparations | 97 out of 1,176 | 92nd |
Source: SEC filing on March 20, 2017.
Conterno's colleagues
We found four more compensation records of executives who worked with Enrique A. Conterno at Lilly Eli & Co in 2016.
2016
John Lechleiter
Lilly Eli & Co
Chief Executive Officer
2016
Derica Rice
Lilly Eli & Co
Chief Financial Officer
2016
Jan Lundberg
Lilly Eli & Co
Executive Vice President, Science and Technology, and President, Lilly Research Laboratories
2016
Michael Harrington
Lilly Eli & Co